ClinicalTrials.Veeva

Menu

Analysis of Sleep Study Data to Assess Depressive Burden (SADB)

M

Medibio

Status

Completed

Conditions

Sleep Disorder
Depressive; Behavioral Disorder
Mood Disorders

Treatments

Device: MEB-001

Study type

Observational

Funder types

Industry

Identifiers

NCT04232267
CIP-0018

Details and patient eligibility

About

This study evaluates the effectiveness of the MEB-001 device in assessing physiological parameters that provide a clinically significant depressive burden screener. This study uses objective physiological markers from MEB-001 to estimate the clinically significant depressive burden as subjectively reported by the subject with the Beck Depression Inventory - II (BDI-II).

Full description

This study evaluates the effectiveness of the MEB-001 device in assessing physiological parameters that provide a clinically significant depressive burden screener. This study uses objective physiological markers from MEB-001 to estimate the clinically significant depressive burden as subjectively reported by the subject with the BDI-II.

This is a two (2)-phase, non-significant risk, cross-sectional, naturalistic, single-arm, multi-center study conducted under a common protocol and designed to:

Phase 1: MEB-001 algorithm development (software medical device). Phase 2: Evaluate the effectiveness of the MEB-001 device in assessing physiological parameters that provide clinically significant depressive burden screener.

Enrollment

329 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject is age ≥18 years and ≤75 years.
  • Subject is willing and able to provide consent.
  • Subject has the ability to read and understand the instructions for the study.
  • Subject is willing to adhere to study procedures.
  • Subject is willing to undergo full night PSG study, as prescribed.

Exclusion criteria

  • Subject has a pacemaker.
  • Subject is suspected or known to have active alcohol or drug abuse (including but not limited to abuse of marijuana).

Trial design

329 participants in 1 patient group

Patients prescribed Polysomnology (PSG - sleep study)
Description:
Patients that are at least 18 years old but not older than 75 years old, who have been referred to a sleep clinic for sleep disturbance.
Treatment:
Device: MEB-001

Trial contacts and locations

5

Loading...

Central trial contact

Melissa A Broich; Archie Defillo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems